International safety notice
Increased risk of cardiovascular death with use of ASV therapy (Weinmann devices SOMNOvent CR and prismaCR), Weinmann Geräte für Medizin GmbH + Co. KG
Germany / BfArM · DEU · Jun 2, 2015
Key facts
| Title | Increased risk of cardiovascular death with use of ASV therapy (Weinmann devices SOMNOvent CR and prismaCR), Weinmann Geräte für Medizin GmbH + Co. KG |
|---|---|
| Regulator | Germany / BfArM |
| Country | DEU |
| Brand | Increased risk of cardiovascular death with use of ASV therapy (Weinmann devices SOMNOvent CR and prismaCR), Weinmann Geräte für Medizin GmbH + Co. KG |
| Manufacturer | Increased risk of cardiovascular death with use of ASV therapy (Weinmann devices SOMNOvent CR and prismaCR), Weinmann Geräte für Medizin GmbH + Co. KG |
| Models | WEINMANN.DEWWW.WEINMANN.DE-547, 698-IDNR, 63391140, 22525, DRESDEFF200, 23470, 24785, DE68200800000507338800SWIFT, 24720, 8678GLÄUBIGERKOMPLEMENTÄRVERWALTUNGSGESELLSCHAFT, 118051598, 118051598-REG.-NR and 21 more |
| Date | Jun 2, 2015 |
| Regulator page | bfarm.de |
At a glance
- No Recall
- No Field safety notice
- 1–9 Matching device models in FDA data
- 100–999 Matching catalog numbers in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1